PRJNA207719: Tissue specific transcriptome profiling
Gene Symbol | Gene ID | Gene Info |
---|---|---|
zeb1b
|
ENSDARG00000013207 | zinc finger E-box binding homeobox 1b |
zeb1a
|
ENSDARG00000016788 | zinc finger E-box binding homeobox 1a |
zeb1b
|
ENSDARG00000113922 | zinc finger E-box binding homeobox 1b |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
zeb1b | dr11_v1_chr12_-_26851726_26851726 | -0.85 | 7.0e-02 | Click! |
zeb1a | dr11_v1_chr2_-_43850637_43850637 | -0.75 | 1.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_20239141 | 6.92 |
ENSDART00000101152
ENSDART00000152473 |
spint2
|
serine peptidase inhibitor, Kunitz type, 2 |
chr22_+_661711 | 4.88 |
ENSDART00000113795
|
elf3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr19_-_30404096 | 4.75 |
ENSDART00000103475
|
agr2
|
anterior gradient 2 |
chr2_+_68789 | 4.58 |
ENSDART00000058569
|
cldn1
|
claudin 1 |
chr22_+_7439476 | 4.51 |
ENSDART00000021594
ENSDART00000063389 |
zgc:92041
|
zgc:92041 |
chr22_+_1170294 | 4.47 |
ENSDART00000159761
ENSDART00000169809 |
irf6
|
interferon regulatory factor 6 |
chr10_-_2942900 | 4.25 |
ENSDART00000002622
|
oclna
|
occludin a |
chr6_-_7776612 | 4.20 |
ENSDART00000190269
|
myh9a
|
myosin, heavy chain 9a, non-muscle |
chr21_-_38153824 | 3.90 |
ENSDART00000151226
|
klf5l
|
Kruppel-like factor 5 like |
chr19_-_30403922 | 3.87 |
ENSDART00000181841
|
agr2
|
anterior gradient 2 |
chr22_+_661505 | 3.78 |
ENSDART00000149460
|
elf3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr1_-_50247 | 3.47 |
ENSDART00000168428
|
ildr1a
|
immunoglobulin-like domain containing receptor 1a |
chr9_+_48007081 | 3.40 |
ENSDART00000060593
ENSDART00000099835 |
zgc:92380
|
zgc:92380 |
chr16_+_17715243 | 3.39 |
ENSDART00000149437
ENSDART00000149596 |
si:dkey-87o1.2
|
si:dkey-87o1.2 |
chr22_-_17677947 | 3.37 |
ENSDART00000139911
|
tjp3
|
tight junction protein 3 |
chr16_-_26676685 | 3.28 |
ENSDART00000103431
|
esrp1
|
epithelial splicing regulatory protein 1 |
chr25_-_22187397 | 3.26 |
ENSDART00000123211
ENSDART00000139110 |
pkp3a
|
plakophilin 3a |
chr15_-_33964897 | 3.16 |
ENSDART00000172075
ENSDART00000158126 ENSDART00000160456 |
lsr
|
lipolysis stimulated lipoprotein receptor |
chr19_-_48010490 | 3.10 |
ENSDART00000159938
|
FBXL19
|
zgc:158376 |
chr19_-_48312109 | 3.04 |
ENSDART00000161103
|
si:ch73-359m17.9
|
si:ch73-359m17.9 |
chr19_+_791538 | 2.99 |
ENSDART00000146554
ENSDART00000138406 |
tmem79a
|
transmembrane protein 79a |
chr3_-_61162750 | 2.98 |
ENSDART00000055064
|
pvalb8
|
parvalbumin 8 |
chr2_-_722156 | 2.90 |
ENSDART00000045770
ENSDART00000169498 |
foxq1a
|
forkhead box Q1a |
chr7_-_53117131 | 2.86 |
ENSDART00000169211
ENSDART00000168890 ENSDART00000172179 ENSDART00000167882 |
cdh1
|
cadherin 1, type 1, E-cadherin (epithelial) |
chr8_-_18667693 | 2.82 |
ENSDART00000100516
|
stap2b
|
signal transducing adaptor family member 2b |
chr16_-_23346095 | 2.77 |
ENSDART00000160546
|
si:dkey-247k7.2
|
si:dkey-247k7.2 |
chr13_+_33606739 | 2.73 |
ENSDART00000026464
|
cfl1l
|
cofilin 1 (non-muscle), like |
chr16_+_23947196 | 2.71 |
ENSDART00000103190
ENSDART00000132961 ENSDART00000147690 ENSDART00000142168 |
apoa4b.2
|
apolipoprotein A-IV b, tandem duplicate 2 |
chr12_-_4243268 | 2.61 |
ENSDART00000131275
|
zgc:92313
|
zgc:92313 |
chr21_-_25741411 | 2.60 |
ENSDART00000101211
|
cldnh
|
claudin h |
chr11_+_10984293 | 2.58 |
ENSDART00000065933
|
itgb6
|
integrin, beta 6 |
chr7_+_35075847 | 2.56 |
ENSDART00000193469
ENSDART00000037346 |
ctrb1
|
chymotrypsinogen B1 |
chr7_-_55648336 | 2.50 |
ENSDART00000147792
ENSDART00000135304 ENSDART00000131923 |
pabpn1l
|
poly(A) binding protein, nuclear 1-like (cytoplasmic) |
chr17_+_2549503 | 2.45 |
ENSDART00000156843
|
si:dkey-248g15.3
|
si:dkey-248g15.3 |
chr4_-_77557279 | 2.44 |
ENSDART00000180113
|
AL935186.10
|
|
chr12_-_46228023 | 2.41 |
ENSDART00000153455
|
si:ch211-226h7.6
|
si:ch211-226h7.6 |
chr22_+_11756040 | 2.39 |
ENSDART00000105808
|
krt97
|
keratin 97 |
chr12_-_11349899 | 2.37 |
ENSDART00000079645
|
zgc:174164
|
zgc:174164 |
chr5_-_65021736 | 2.37 |
ENSDART00000162368
ENSDART00000161876 |
anxa1c
|
annexin A1c |
chr10_+_2715548 | 2.34 |
ENSDART00000130793
|
grk5
|
G protein-coupled receptor kinase 5 |
chr12_-_46252062 | 2.33 |
ENSDART00000153223
|
si:ch211-226h7.5
|
si:ch211-226h7.5 |
chr3_-_33970190 | 2.30 |
ENSDART00000151238
|
ighj2-5
|
ighj2-5 |
chr22_+_7439186 | 2.28 |
ENSDART00000190667
|
zgc:92041
|
zgc:92041 |
chr17_-_32426392 | 2.26 |
ENSDART00000148455
ENSDART00000149885 ENSDART00000179314 |
grhl1
|
grainyhead-like transcription factor 1 |
chr1_+_56180416 | 2.23 |
ENSDART00000089358
|
crb3b
|
crumbs homolog 3b |
chr15_-_107900 | 2.22 |
ENSDART00000193184
|
apoa1b
|
apolipoprotein A-Ib |
chr16_-_20312146 | 2.22 |
ENSDART00000134980
|
si:dkeyp-86h10.3
|
si:dkeyp-86h10.3 |
chr17_-_2596125 | 2.20 |
ENSDART00000175740
|
zp3.2
|
zona pellucida glycoprotein 3, tandem duplicate 2 |
chr2_+_15612755 | 2.19 |
ENSDART00000003035
|
amy2a
|
amylase, alpha 2A (pancreatic) |
chr25_+_22107643 | 2.18 |
ENSDART00000089680
|
sigirr
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr14_+_48862987 | 2.15 |
ENSDART00000167810
|
zgc:154054
|
zgc:154054 |
chr21_+_30351256 | 2.15 |
ENSDART00000078341
|
foxi3a
|
forkhead box I3a |
chr22_-_15578402 | 2.14 |
ENSDART00000062986
|
hsh2d
|
hematopoietic SH2 domain containing |
chr1_+_58922027 | 2.14 |
ENSDART00000159479
|
trip10b
|
thyroid hormone receptor interactor 10b |
chr22_+_7480465 | 2.14 |
ENSDART00000034545
|
CELA1 (1 of many)
|
zgc:92745 |
chr13_+_24750078 | 2.12 |
ENSDART00000021053
|
col17a1b
|
collagen, type XVII, alpha 1b |
chr19_+_10855158 | 2.11 |
ENSDART00000172219
ENSDART00000170826 |
apoea
|
apolipoprotein Ea |
chr1_-_45177373 | 2.10 |
ENSDART00000143142
ENSDART00000034549 |
zgc:111983
|
zgc:111983 |
chr24_-_20444844 | 2.09 |
ENSDART00000048940
|
vill
|
villin-like |
chr22_+_3914318 | 2.03 |
ENSDART00000188774
ENSDART00000082034 |
FO904903.1
|
Danio rerio major histocompatibility complex class I ULA (mhc1ula), mRNA. |
chr5_-_37959874 | 1.97 |
ENSDART00000031719
|
mpzl2b
|
myelin protein zero-like 2b |
chr19_-_5332784 | 1.97 |
ENSDART00000010373
|
krt1-19d
|
keratin, type 1, gene 19d |
chr10_-_34002185 | 1.95 |
ENSDART00000046599
|
zar1l
|
zygote arrest 1-like |
chr21_-_22648007 | 1.92 |
ENSDART00000121788
|
gig2l
|
grass carp reovirus (GCRV)-induced gene 2l |
chr3_-_19561058 | 1.91 |
ENSDART00000079323
|
zgc:163079
|
zgc:163079 |
chr17_+_2552453 | 1.89 |
ENSDART00000189889
|
si:dkey-248g15.3
|
si:dkey-248g15.3 |
chr12_+_5708400 | 1.89 |
ENSDART00000017191
|
dlx3b
|
distal-less homeobox 3b |
chr11_-_11518469 | 1.88 |
ENSDART00000104254
|
krt15
|
keratin 15 |
chr17_-_26867725 | 1.88 |
ENSDART00000153590
|
si:dkey-221l4.10
|
si:dkey-221l4.10 |
chr23_-_10175898 | 1.86 |
ENSDART00000146185
|
krt5
|
keratin 5 |
chr17_-_30652738 | 1.86 |
ENSDART00000154960
|
sh3yl1
|
SH3 and SYLF domain containing 1 |
chr11_+_37216668 | 1.85 |
ENSDART00000173076
|
zgc:112265
|
zgc:112265 |
chr22_+_7497319 | 1.83 |
ENSDART00000034564
|
CELA1 (1 of many)
|
zgc:92511 |
chr25_-_169291 | 1.80 |
ENSDART00000128344
|
lipcb
|
lipase, hepatic b |
chr1_-_52437056 | 1.78 |
ENSDART00000138337
|
si:ch211-217k17.12
|
si:ch211-217k17.12 |
chr19_-_40198478 | 1.78 |
ENSDART00000191736
|
grn2
|
granulin 2 |
chr4_-_68563862 | 1.77 |
ENSDART00000182970
|
BX548011.2
|
|
chr4_+_76671012 | 1.76 |
ENSDART00000005585
|
ms4a17a.2
|
membrane-spanning 4-domains, subfamily A, member 17a.2 |
chr16_+_23921777 | 1.75 |
ENSDART00000163213
|
apoa4b.3
|
apolipoprotein A-IV b, tandem duplicate 3 |
chr21_-_30293224 | 1.74 |
ENSDART00000101051
|
slbp2
|
stem-loop binding protein 2 |
chr15_-_43164591 | 1.71 |
ENSDART00000171305
|
ap1s3a
|
adaptor-related protein complex 1, sigma 3 subunit, a |
chr18_-_46354269 | 1.71 |
ENSDART00000010813
|
foxa3
|
forkhead box A3 |
chr15_-_41714329 | 1.70 |
ENSDART00000154113
|
CR853294.1
|
|
chr10_-_35149513 | 1.70 |
ENSDART00000063434
ENSDART00000131291 |
ripk4
|
receptor-interacting serine-threonine kinase 4 |
chr1_-_2051599 | 1.69 |
ENSDART00000041936
|
oxgr1a.1
|
oxoglutarate (alpha-ketoglutarate) receptor 1a, tandem duplicate 1 |
chr1_-_45146834 | 1.68 |
ENSDART00000144997
|
si:ch211-239f4.6
|
si:ch211-239f4.6 |
chr8_+_2478862 | 1.68 |
ENSDART00000131739
|
si:dkeyp-51b9.3
|
si:dkeyp-51b9.3 |
chr16_+_23921610 | 1.67 |
ENSDART00000143855
|
apoa4b.3
|
apolipoprotein A-IV b, tandem duplicate 3 |
chr4_-_68564988 | 1.67 |
ENSDART00000191212
|
BX548011.3
|
|
chr24_-_31904924 | 1.66 |
ENSDART00000156060
ENSDART00000129741 ENSDART00000154276 |
si:ch73-78o10.1
|
si:ch73-78o10.1 |
chr18_-_38271298 | 1.65 |
ENSDART00000143016
|
caprin1b
|
cell cycle associated protein 1b |
chr17_+_26965351 | 1.65 |
ENSDART00000114215
ENSDART00000147192 |
grhl3
|
grainyhead-like transcription factor 3 |
chr25_-_17395315 | 1.64 |
ENSDART00000064596
|
cyp2x8
|
cytochrome P450, family 2, subfamily X, polypeptide 8 |
chr20_-_3238110 | 1.64 |
ENSDART00000008077
|
spint1b
|
serine peptidase inhibitor, Kunitz type 1 b |
chr20_+_1398564 | 1.63 |
ENSDART00000002242
|
leg1.2
|
liver-enriched gene 1, tandem duplicate 2 |
chr21_-_25741096 | 1.62 |
ENSDART00000181756
|
cldnh
|
claudin h |
chr11_-_45429199 | 1.62 |
ENSDART00000173111
|
rfc4
|
replication factor C (activator 1) 4 |
chr14_+_14568437 | 1.61 |
ENSDART00000164749
|
pcdh20
|
protocadherin 20 |
chr20_-_42702832 | 1.60 |
ENSDART00000134689
ENSDART00000045816 |
plg
|
plasminogen |
chr12_-_46315898 | 1.60 |
ENSDART00000153138
|
si:ch211-226h7.3
|
si:ch211-226h7.3 |
chr3_-_33970998 | 1.60 |
ENSDART00000151527
|
ighj2-2
|
immunoglobulin heavy joining 2-2 |
chr16_+_17714664 | 1.59 |
ENSDART00000149042
|
si:dkey-87o1.2
|
si:dkey-87o1.2 |
chr8_+_25302172 | 1.58 |
ENSDART00000046182
ENSDART00000145316 |
gstm.3
|
glutathione S-transferase mu tandem duplicate 3 |
chr22_+_7472420 | 1.57 |
ENSDART00000132049
|
CELA1 (1 of many)
|
si:dkey-57c15.4 |
chr1_+_26411496 | 1.57 |
ENSDART00000112263
|
arhgef38
|
Rho guanine nucleotide exchange factor (GEF) 38 |
chr7_+_30392613 | 1.57 |
ENSDART00000075508
|
lipca
|
lipase, hepatic a |
chr21_-_7928101 | 1.56 |
ENSDART00000151543
ENSDART00000114982 |
f2rl1.2
|
coagulation factor II (thrombin) receptor-like 1, tandem duplicate 2 |
chr2_+_49457626 | 1.55 |
ENSDART00000129967
|
sh3gl1a
|
SH3-domain GRB2-like 1a |
chr2_+_49457449 | 1.54 |
ENSDART00000185470
|
sh3gl1a
|
SH3-domain GRB2-like 1a |
chr20_+_1412193 | 1.54 |
ENSDART00000064419
|
leg1.1
|
liver-enriched gene 1, tandem duplicate 1 |
chr20_+_305035 | 1.54 |
ENSDART00000104807
|
si:dkey-119m7.4
|
si:dkey-119m7.4 |
chr5_+_26212621 | 1.53 |
ENSDART00000134432
|
oclnb
|
occludin b |
chr22_+_7742211 | 1.53 |
ENSDART00000140896
|
CELA1 (1 of many)
|
zgc:92511 |
chr7_-_34265481 | 1.51 |
ENSDART00000173596
|
si:ch211-98n17.5
|
si:ch211-98n17.5 |
chr7_-_38658411 | 1.51 |
ENSDART00000109463
ENSDART00000017155 |
npsn
|
nephrosin |
chr15_-_47929455 | 1.50 |
ENSDART00000064462
|
psma6l
|
proteasome subunit alpha 6, like |
chr5_+_30384554 | 1.50 |
ENSDART00000135483
|
zgc:158412
|
zgc:158412 |
chr23_+_31815423 | 1.50 |
ENSDART00000075730
ENSDART00000075726 |
myb
|
v-myb avian myeloblastosis viral oncogene homolog |
chr24_-_26369185 | 1.49 |
ENSDART00000080039
|
lrrc31
|
leucine rich repeat containing 31 |
chr25_+_10416583 | 1.49 |
ENSDART00000073907
|
ehf
|
ets homologous factor |
chr16_-_42186093 | 1.49 |
ENSDART00000076030
|
fbl
|
fibrillarin |
chr4_+_18843015 | 1.47 |
ENSDART00000152086
ENSDART00000066977 ENSDART00000132567 |
bik
|
BCL2 interacting killer |
chr17_+_24843401 | 1.47 |
ENSDART00000110179
|
cx34.4
|
connexin 34.4 |
chr8_-_11170114 | 1.46 |
ENSDART00000133532
|
si:ch211-204d2.4
|
si:ch211-204d2.4 |
chr16_+_28754403 | 1.46 |
ENSDART00000103340
|
s100v1
|
S100 calcium binding protein V1 |
chr13_-_15994419 | 1.45 |
ENSDART00000079724
ENSDART00000042377 ENSDART00000046079 ENSDART00000050481 ENSDART00000016430 |
ikzf1
|
IKAROS family zinc finger 1 (Ikaros) |
chr10_-_15053507 | 1.45 |
ENSDART00000157446
ENSDART00000170441 |
CLDN23
|
si:ch211-95j8.5 |
chr13_-_36034582 | 1.45 |
ENSDART00000133565
|
si:dkey-157l19.2
|
si:dkey-157l19.2 |
chr8_+_999421 | 1.45 |
ENSDART00000149528
|
fabp1b.1
|
fatty acid binding protein 1b, tandem duplicate 1 |
chr3_+_49021079 | 1.45 |
ENSDART00000162012
|
zgc:163083
|
zgc:163083 |
chr9_-_44948488 | 1.44 |
ENSDART00000059228
|
vil1
|
villin 1 |
chr23_-_29824146 | 1.44 |
ENSDART00000020616
|
zgc:194189
|
zgc:194189 |
chr22_+_19494996 | 1.44 |
ENSDART00000140829
ENSDART00000135168 |
si:dkey-78l4.10
|
si:dkey-78l4.10 |
chr21_-_7940043 | 1.44 |
ENSDART00000099733
ENSDART00000136671 |
f2rl1.1
|
coagulation factor II (thrombin) receptor-like 1, tandem duplicate 1 |
chr1_-_7951002 | 1.43 |
ENSDART00000138187
|
si:dkey-79f11.8
|
si:dkey-79f11.8 |
chr7_-_8416750 | 1.43 |
ENSDART00000181857
|
jac1
|
jacalin 1 |
chr2_-_32237916 | 1.43 |
ENSDART00000141418
|
fam49ba
|
family with sequence similarity 49, member Ba |
chr4_-_178510 | 1.43 |
ENSDART00000169805
|
eps8
|
epidermal growth factor receptor pathway substrate 8 |
chr19_+_48141623 | 1.43 |
ENSDART00000170439
|
btr30
|
bloodthirsty-related gene family, member 30 |
chr17_+_43868441 | 1.42 |
ENSDART00000134272
|
zgc:66313
|
zgc:66313 |
chr5_-_22590739 | 1.41 |
ENSDART00000141555
|
si:dkey-103e21.5
|
si:dkey-103e21.5 |
chr19_+_4800549 | 1.41 |
ENSDART00000056235
|
st3gal1l
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1, like |
chr1_-_7603734 | 1.41 |
ENSDART00000009315
|
mxb
|
myxovirus (influenza) resistance B |
chr7_+_55149001 | 1.40 |
ENSDART00000148642
|
cdh31
|
cadherin 31 |
chr15_-_108414 | 1.39 |
ENSDART00000170044
|
apoa1b
|
apolipoprotein A-Ib |
chr23_+_46157638 | 1.38 |
ENSDART00000076048
|
btr32
|
bloodthirsty-related gene family, member 32 |
chr3_+_8224622 | 1.38 |
ENSDART00000138670
|
si:ch73-379f5.5
|
si:ch73-379f5.5 |
chr4_-_13518381 | 1.38 |
ENSDART00000067153
|
ifng1-1
|
interferon, gamma 1-1 |
chr14_+_15543331 | 1.38 |
ENSDART00000167025
|
si:dkey-203a12.7
|
si:dkey-203a12.7 |
chr21_-_217589 | 1.38 |
ENSDART00000185017
|
CZQB01146713.1
|
|
chr21_-_3700334 | 1.37 |
ENSDART00000137844
|
atp8b1
|
ATPase phospholipid transporting 8B1 |
chr14_+_32964 | 1.37 |
ENSDART00000166173
|
lyar
|
Ly1 antibody reactive homolog (mouse) |
chr13_+_18533005 | 1.36 |
ENSDART00000136024
|
ftr14l
|
finTRIM family, member 14-like |
chr7_+_32901658 | 1.36 |
ENSDART00000115420
|
ano9b
|
anoctamin 9b |
chr7_+_73670137 | 1.36 |
ENSDART00000050357
|
btr12
|
bloodthirsty-related gene family, member 12 |
chr3_-_33970431 | 1.35 |
ENSDART00000151313
|
ighj2-4
|
ighj2-4 |
chr3_+_21189766 | 1.35 |
ENSDART00000078807
|
zgc:123295
|
zgc:123295 |
chr11_+_329687 | 1.34 |
ENSDART00000172882
|
cyp27b1
|
cytochrome P450, family 27, subfamily B, polypeptide 1 |
chr15_-_576135 | 1.34 |
ENSDART00000124170
|
cbln20
|
cerebellin 20 |
chr17_-_2595736 | 1.34 |
ENSDART00000128797
|
zp3.2
|
zona pellucida glycoprotein 3, tandem duplicate 2 |
chr18_+_44703343 | 1.33 |
ENSDART00000131510
|
b3gnt2l
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, like |
chr1_+_59538755 | 1.33 |
ENSDART00000166354
|
sp6
|
Sp6 transcription factor |
chr13_-_21672131 | 1.33 |
ENSDART00000067537
|
elovl6l
|
ELOVL family member 6, elongation of long chain fatty acids like |
chr14_+_6953244 | 1.33 |
ENSDART00000159470
|
rack1
|
receptor for activated C kinase 1 |
chr20_+_26556174 | 1.32 |
ENSDART00000138492
|
irf4b
|
interferon regulatory factor 4b |
chr15_-_21165237 | 1.32 |
ENSDART00000157069
|
A2ML1 (1 of many)
|
si:ch211-212c13.8 |
chr25_-_16600811 | 1.32 |
ENSDART00000011397
|
cpa2
|
carboxypeptidase A2 (pancreatic) |
chr25_+_3217419 | 1.32 |
ENSDART00000104859
|
rccd1
|
RCC1 domain containing 1 |
chr6_-_609880 | 1.31 |
ENSDART00000149248
ENSDART00000148867 ENSDART00000149414 ENSDART00000148552 ENSDART00000148391 |
lgals2b
|
lectin, galactoside-binding, soluble, 2b |
chr3_-_39488482 | 1.31 |
ENSDART00000135192
|
zgc:100868
|
zgc:100868 |
chr16_-_9830451 | 1.31 |
ENSDART00000148528
|
grhl2a
|
grainyhead-like transcription factor 2a |
chr6_+_153146 | 1.30 |
ENSDART00000097468
|
zglp1
|
zinc finger, GATA-like protein 1 |
chr2_-_47620806 | 1.30 |
ENSDART00000038228
|
ap1s3b
|
adaptor-related protein complex 1, sigma 3 subunit, b |
chr24_-_36593876 | 1.30 |
ENSDART00000160901
|
CABZ01055365.1
|
|
chr1_-_59095035 | 1.29 |
ENSDART00000130791
|
MFAP4 (1 of many)
|
wu:fj11g02 |
chr7_+_66565930 | 1.29 |
ENSDART00000154597
|
tmem176l.3b
|
transmembrane protein 176l.3b |
chr16_-_46664465 | 1.29 |
ENSDART00000135364
|
tmem176l.4
|
transmembrane protein 176l.4 |
chr3_-_39488639 | 1.27 |
ENSDART00000161644
|
zgc:100868
|
zgc:100868 |
chr5_-_67471375 | 1.27 |
ENSDART00000147009
|
si:dkey-251i10.2
|
si:dkey-251i10.2 |
chr17_-_42988356 | 1.27 |
ENSDART00000024558
|
zgc:92137
|
zgc:92137 |
chr6_+_36877968 | 1.26 |
ENSDART00000155187
|
traf3ip2l
|
TRAF3 interacting protein 2-like |
chr2_-_58075414 | 1.26 |
ENSDART00000161920
|
nectin4
|
nectin cell adhesion molecule 4 |
chr4_-_12725513 | 1.25 |
ENSDART00000132286
|
mgst1.2
|
microsomal glutathione S-transferase 1.2 |
chr14_+_22022441 | 1.25 |
ENSDART00000149121
|
clcf1
|
cardiotrophin-like cytokine factor 1 |
chr22_+_2960280 | 1.25 |
ENSDART00000134188
ENSDART00000134451 ENSDART00000139894 |
impact
|
impact RWD domain protein |
chr2_-_8648440 | 1.25 |
ENSDART00000135743
|
si:ch211-71m22.3
|
si:ch211-71m22.3 |
chr7_+_35068036 | 1.25 |
ENSDART00000022139
|
zgc:136461
|
zgc:136461 |
chr3_+_29469283 | 1.25 |
ENSDART00000103592
|
fam83fa
|
family with sequence similarity 83, member Fa |
chr21_+_10577527 | 1.25 |
ENSDART00000165070
ENSDART00000127963 |
ccbe1
|
collagen and calcium binding EGF domains 1 |
chr6_-_33913184 | 1.25 |
ENSDART00000146373
|
nasp
|
nuclear autoantigenic sperm protein (histone-binding) |
chr23_-_31428763 | 1.24 |
ENSDART00000053545
|
zgc:153284
|
zgc:153284 |
chr5_-_33236637 | 1.24 |
ENSDART00000085512
ENSDART00000144694 |
kank1b
|
KN motif and ankyrin repeat domains 1b |
chr19_-_15192638 | 1.24 |
ENSDART00000048151
|
phactr4a
|
phosphatase and actin regulator 4a |
chr12_+_20352400 | 1.23 |
ENSDART00000066383
|
hbae5
|
hemoglobin, alpha embryonic 5 |
chr16_+_13427967 | 1.23 |
ENSDART00000038196
|
zgc:101640
|
zgc:101640 |
chr20_-_17041025 | 1.22 |
ENSDART00000063764
|
si:dkey-5n18.1
|
si:dkey-5n18.1 |
chr21_-_22676323 | 1.22 |
ENSDART00000167392
|
gig2h
|
grass carp reovirus (GCRV)-induced gene 2h |
chr10_+_9561066 | 1.22 |
ENSDART00000136281
|
si:ch211-243g18.2
|
si:ch211-243g18.2 |
chr18_-_977075 | 1.21 |
ENSDART00000032392
|
dhdhl
|
dihydrodiol dehydrogenase (dimeric), like |
chr21_-_25295087 | 1.21 |
ENSDART00000087910
ENSDART00000147860 |
st14b
|
suppression of tumorigenicity 14 (colon carcinoma) b |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 5.4 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.1 | 5.3 | GO:0010873 | regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) |
0.9 | 3.7 | GO:0097242 | regulation of nitric-oxide synthase activity(GO:0050999) positive regulation of nitric-oxide synthase activity(GO:0051000) beta-amyloid clearance(GO:0097242) regulation of beta-amyloid clearance(GO:1900221) |
0.9 | 2.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.9 | 8.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.8 | 3.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.6 | 1.9 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.6 | 1.7 | GO:0048785 | hatching gland development(GO:0048785) |
0.5 | 1.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.5 | 3.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 2.9 | GO:0090134 | mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
0.5 | 1.4 | GO:0046415 | urate catabolic process(GO:0019628) urate metabolic process(GO:0046415) |
0.4 | 1.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.4 | 2.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 3.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.4 | 2.4 | GO:2000516 | neutrophil apoptotic process(GO:0001781) regulation of T-helper 1 type immune response(GO:0002825) positive regulation of T-helper 1 type immune response(GO:0002827) negative regulation of type 2 immune response(GO:0002829) inflammatory cell apoptotic process(GO:0006925) regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of phospholipase A2 activity(GO:0032429) interleukin-2 production(GO:0032623) regulation of interleukin-2 production(GO:0032663) positive regulation of interleukin-2 production(GO:0032743) myeloid cell apoptotic process(GO:0033028) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) regulation of myeloid cell apoptotic process(GO:0033032) positive regulation of myeloid cell apoptotic process(GO:0033034) T-helper 1 type immune response(GO:0042088) positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) T-helper 1 cell differentiation(GO:0045063) positive regulation of T-helper cell differentiation(GO:0045624) regulation of T-helper 1 cell differentiation(GO:0045625) positive regulation of T-helper 1 cell differentiation(GO:0045627) regulation of T-helper 2 cell differentiation(GO:0045628) negative regulation of T-helper 2 cell differentiation(GO:0045629) positive regulation of fatty acid biosynthetic process(GO:0045723) positive regulation of alpha-beta T cell differentiation(GO:0046638) neutrophil clearance(GO:0097350) negative regulation of phospholipase A2 activity(GO:1900138) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 2.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.9 | GO:0070292 | N-acylphosphatidylethanolamine metabolic process(GO:0070292) |
0.4 | 1.1 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.4 | 3.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 3.4 | GO:0030104 | water homeostasis(GO:0030104) |
0.4 | 1.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) regulation of lamellipodium morphogenesis(GO:2000392) |
0.4 | 6.1 | GO:2000344 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) egg coat formation(GO:0035803) regulation of acrosome reaction(GO:0060046) positive regulation of acrosome reaction(GO:2000344) |
0.3 | 1.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.3 | 1.0 | GO:0030237 | female sex determination(GO:0030237) |
0.3 | 0.3 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) RNA 5'-end processing(GO:0000966) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.3 | 0.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.7 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.3 | 0.8 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.3 | 1.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 1.5 | GO:0010269 | response to selenium ion(GO:0010269) |
0.3 | 1.3 | GO:0070301 | response to acidic pH(GO:0010447) cellular response to hydrogen peroxide(GO:0070301) |
0.2 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 1.5 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) regulation of neutrophil differentiation(GO:0045658) |
0.2 | 2.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 11.5 | GO:0043297 | apical junction assembly(GO:0043297) bicellular tight junction assembly(GO:0070830) |
0.2 | 1.1 | GO:0010693 | regulation of alkaline phosphatase activity(GO:0010692) negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 1.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.2 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) positive regulation of monooxygenase activity(GO:0032770) |
0.2 | 1.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 1.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.7 | GO:0070589 | cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 0.7 | GO:0046125 | deoxyribonucleoside metabolic process(GO:0009120) thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 1.3 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.6 | GO:0009595 | detection of biotic stimulus(GO:0009595) detection of bacterium(GO:0016045) detection of other organism(GO:0098543) detection of external biotic stimulus(GO:0098581) |
0.2 | 1.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 2.0 | GO:0018120 | peptidyl-arginine ADP-ribosylation(GO:0018120) |
0.2 | 0.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.2 | 1.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.2 | 0.6 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 0.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.2 | GO:0060965 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.2 | 2.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 4.9 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.2 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 1.8 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) |
0.2 | 1.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 2.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) linoleic acid metabolic process(GO:0043651) hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 5.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.7 | GO:0009097 | isoleucine metabolic process(GO:0006549) isoleucine biosynthetic process(GO:0009097) |
0.2 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 4.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) positive regulation of receptor activity(GO:2000273) |
0.2 | 3.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.2 | 1.0 | GO:0046874 | quinolinate biosynthetic process(GO:0019805) quinolinate metabolic process(GO:0046874) |
0.2 | 1.5 | GO:1990402 | embryonic liver development(GO:1990402) |
0.2 | 0.7 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.2 | 0.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 1.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.2 | 0.7 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.2 | 1.0 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.2 | 0.5 | GO:1902571 | regulation of serine-type peptidase activity(GO:1902571) |
0.2 | 0.7 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 2.7 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.2 | 0.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 0.5 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 1.5 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.2 | 0.8 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.2 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.5 | GO:0006589 | octopamine biosynthetic process(GO:0006589) dopamine catabolic process(GO:0042420) norepinephrine biosynthetic process(GO:0042421) octopamine metabolic process(GO:0046333) |
0.2 | 4.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.9 | GO:0098789 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.5 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.2 | 0.6 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 1.1 | GO:0060855 | venous endothelial cell migration involved in lymph vessel development(GO:0060855) |
0.2 | 0.9 | GO:1902946 | positive regulation of receptor-mediated endocytosis(GO:0048260) protein localization to early endosome(GO:1902946) |
0.2 | 2.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.4 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 3.0 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 1.5 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.1 | 0.7 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.4 | GO:0090435 | protein targeting to nuclear inner membrane(GO:0036228) protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.4 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 3.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.4 | GO:0042543 | protein N-linked glycosylation via arginine(GO:0042543) |
0.1 | 0.7 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.4 | GO:0071706 | tumor necrosis factor production(GO:0032640) tumor necrosis factor superfamily cytokine production(GO:0071706) |
0.1 | 1.0 | GO:0050482 | icosanoid secretion(GO:0032309) arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.4 | GO:1903173 | fatty alcohol metabolic process(GO:1903173) |
0.1 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.7 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.1 | 0.4 | GO:0098801 | renal system process involved in regulation of blood volume(GO:0001977) renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) regulation of glomerular filtration(GO:0003093) regulation of renal system process(GO:0098801) |
0.1 | 0.9 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.9 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 2.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.4 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.1 | 0.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.3 | GO:0048521 | negative regulation of behavior(GO:0048521) negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.5 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
0.1 | 0.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.5 | GO:0033301 | cell cycle comprising mitosis without cytokinesis(GO:0033301) |
0.1 | 1.2 | GO:0034340 | response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.9 | GO:0045905 | positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.4 | GO:0048341 | paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
0.1 | 0.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 1.5 | GO:2000406 | positive regulation of lymphocyte migration(GO:2000403) positive regulation of T cell migration(GO:2000406) |
0.1 | 1.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:0055057 | neuroblast division(GO:0055057) positive regulation of stem cell proliferation(GO:2000648) |
0.1 | 0.7 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 1.3 | GO:0006032 | chitin catabolic process(GO:0006032) |
0.1 | 0.5 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 1.8 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.8 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.1 | 14.1 | GO:1990266 | neutrophil migration(GO:1990266) |
0.1 | 0.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 2.0 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.8 | GO:1990511 | piRNA biosynthetic process(GO:1990511) |
0.1 | 0.4 | GO:0048795 | swim bladder morphogenesis(GO:0048795) |
0.1 | 2.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.8 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.1 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 1.2 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 1.1 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.4 | GO:0006598 | polyamine catabolic process(GO:0006598) putrescine catabolic process(GO:0009447) |
0.1 | 1.4 | GO:0001678 | cellular glucose homeostasis(GO:0001678) |
0.1 | 2.0 | GO:0001843 | neural tube closure(GO:0001843) |
0.1 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.8 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.6 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 2.1 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 1.4 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.1 | 1.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 1.0 | GO:0014036 | neural crest cell fate commitment(GO:0014034) neural crest cell fate specification(GO:0014036) |
0.1 | 0.3 | GO:1990575 | mitochondrial ornithine transport(GO:0000066) mitochondrial L-ornithine transmembrane transport(GO:1990575) |
0.1 | 0.3 | GO:0003400 | regulation of COPII vesicle coating(GO:0003400) regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis(GO:0090113) |
0.1 | 0.4 | GO:0048903 | anterior lateral line neuromast hair cell differentiation(GO:0048903) |
0.1 | 0.8 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 2.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 1.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 2.2 | GO:0043588 | skin development(GO:0043588) |
0.1 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) threonine catabolic process(GO:0006567) |
0.1 | 0.8 | GO:0042664 | negative regulation of endodermal cell fate specification(GO:0042664) |
0.1 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.4 | GO:0006272 | leading strand elongation(GO:0006272) |
0.1 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.4 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) regulation of cellular amine metabolic process(GO:0033238) |
0.1 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 1.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0070084 | protein initiator methionine removal(GO:0070084) |
0.1 | 0.9 | GO:2001236 | regulation of extrinsic apoptotic signaling pathway(GO:2001236) |
0.1 | 0.3 | GO:0003173 | ventriculo bulbo valve development(GO:0003173) |
0.1 | 0.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.6 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.1 | 0.8 | GO:0042531 | tyrosine phosphorylation of STAT protein(GO:0007260) regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 5.9 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.5 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 0.3 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.1 | 0.9 | GO:0030719 | P granule organization(GO:0030719) |
0.1 | 0.5 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.1 | 0.8 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.1 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 1.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.6 | GO:0060872 | semicircular canal development(GO:0060872) |
0.1 | 0.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.8 | GO:0031274 | pseudopodium organization(GO:0031268) pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.7 | GO:1901099 | histone dephosphorylation(GO:0016576) negative regulation of signal transduction in absence of ligand(GO:1901099) regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 1.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 1.4 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.1 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.4 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.1 | GO:0050820 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.4 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.6 | GO:0048923 | posterior lateral line neuromast hair cell differentiation(GO:0048923) |
0.1 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 3.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:0055014 | atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.5 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 1.1 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.9 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.5 | GO:0048662 | regulation of smooth muscle cell proliferation(GO:0048660) negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 0.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 3.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 1.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0021553 | olfactory nerve development(GO:0021553) olfactory nerve morphogenesis(GO:0021627) olfactory nerve formation(GO:0021628) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.3 | GO:0090208 | regulation of triglyceride biosynthetic process(GO:0010866) positive regulation of triglyceride biosynthetic process(GO:0010867) positive regulation of triglyceride metabolic process(GO:0090208) |
0.1 | 1.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 1.2 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.2 | GO:0070285 | pigment cell development(GO:0070285) |
0.1 | 0.7 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.2 | GO:0046294 | formaldehyde metabolic process(GO:0046292) formaldehyde catabolic process(GO:0046294) |
0.1 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) glycerol-3-phosphate catabolic process(GO:0046168) |
0.1 | 1.0 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.2 | GO:0070197 | telomere localization(GO:0034397) telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic telomere clustering(GO:0045141) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.4 | GO:0001840 | neural plate development(GO:0001840) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.1 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 1.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.7 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.5 | GO:0046959 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.1 | 0.9 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 1.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.7 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.4 | GO:0072048 | anterior/posterior pattern specification involved in pronephros development(GO:0034672) pattern specification involved in pronephros development(GO:0039017) pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.8 | GO:0042476 | odontogenesis(GO:0042476) |
0.1 | 0.2 | GO:0046755 | virion assembly(GO:0019068) virus maturation(GO:0019075) multi-organism membrane organization(GO:0044803) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.2 | GO:0060956 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
0.1 | 0.2 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 7.3 | GO:0006954 | inflammatory response(GO:0006954) |
0.1 | 0.8 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) complement activation, classical pathway(GO:0006958) |
0.1 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 5.2 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 0.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.4 | GO:0003188 | heart valve formation(GO:0003188) atrioventricular valve formation(GO:0003190) |
0.1 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 2.6 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) positive regulation of peptidase activity(GO:0010952) |
0.0 | 0.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 5.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.8 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.0 | 0.3 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.0 | 1.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 3.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.2 | GO:0048855 | adenohypophysis morphogenesis(GO:0048855) |
0.0 | 1.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 5.6 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 1.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 4.0 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 0.2 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) |
0.0 | 0.2 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.0 | 0.7 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.3 | GO:0031106 | septin ring organization(GO:0031106) septin cytoskeleton organization(GO:0032185) |
0.0 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 1.9 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.9 | GO:0032438 | melanosome organization(GO:0032438) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 1.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.9 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 1.2 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 1.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 1.0 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.5 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 1.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.3 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 1.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) |
0.0 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.7 | GO:0002440 | production of molecular mediator of immune response(GO:0002440) |
0.0 | 0.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.8 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 1.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.2 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.0 | 0.4 | GO:0009749 | response to carbohydrate(GO:0009743) response to hexose(GO:0009746) response to glucose(GO:0009749) response to monosaccharide(GO:0034284) |
0.0 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0006843 | mitochondrial citrate transport(GO:0006843) |
0.0 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.2 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.5 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.2 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.0 | 0.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.7 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.2 | GO:0035545 | determination of left/right asymmetry in diencephalon(GO:0035462) determination of left/right asymmetry in nervous system(GO:0035545) |
0.0 | 0.2 | GO:0015864 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0048823 | nucleate erythrocyte development(GO:0048823) |
0.0 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.3 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.2 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.1 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:2001286 | optomotor response(GO:0071632) caveolin-mediated endocytosis(GO:0072584) negative regulation of clathrin-mediated endocytosis(GO:1900186) regulation of caveolin-mediated endocytosis(GO:2001286) negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 2.2 | GO:0070121 | Kupffer's vesicle development(GO:0070121) |
0.0 | 0.2 | GO:0038065 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.2 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.0 | 0.3 | GO:0046247 | carotene metabolic process(GO:0016119) carotene catabolic process(GO:0016121) terpene metabolic process(GO:0042214) terpene catabolic process(GO:0046247) |
0.0 | 0.1 | GO:0048211 | Golgi vesicle docking(GO:0048211) |
0.0 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.5 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.3 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.1 | GO:0051645 | Golgi localization(GO:0051645) maintenance of centrosome location(GO:0051661) |
0.0 | 0.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 2.6 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.4 | GO:0048264 | determination of ventral identity(GO:0048264) |
0.0 | 0.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.3 | GO:0050670 | regulation of mononuclear cell proliferation(GO:0032944) regulation of lymphocyte proliferation(GO:0050670) regulation of leukocyte proliferation(GO:0070663) |
0.0 | 28.2 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.1 | GO:0072091 | regulation of stem cell proliferation(GO:0072091) |
0.0 | 0.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) G-protein coupled receptor internalization(GO:0002031) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.0 | 0.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 2.2 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 8.2 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0051101 | histone H3-K79 methylation(GO:0034729) regulation of DNA binding(GO:0051101) regulation of transcription regulatory region DNA binding(GO:2000677) |
0.0 | 0.1 | GO:0021982 | pineal gland development(GO:0021982) |
0.0 | 1.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.2 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.0 | GO:0060039 | pericardium development(GO:0060039) visceral serous pericardium development(GO:0061032) |
0.0 | 1.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.2 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.2 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.0 | 0.1 | GO:2000826 | regulation of heart morphogenesis(GO:2000826) |
0.0 | 0.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 1.0 | GO:0050673 | epithelial cell proliferation(GO:0050673) |
0.0 | 1.5 | GO:0055123 | digestive system development(GO:0055123) |
0.0 | 0.1 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.0 | GO:1901052 | sarcosine metabolic process(GO:1901052) |
0.0 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 | 0.2 | GO:0036368 | cone photoresponse recovery(GO:0036368) |
0.0 | 0.2 | GO:0003428 | growth plate cartilage morphogenesis(GO:0003422) chondrocyte intercalation involved in growth plate cartilage morphogenesis(GO:0003428) |
0.0 | 0.3 | GO:0002574 | thrombocyte differentiation(GO:0002574) |
0.0 | 0.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
0.0 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.1 | GO:1904036 | negative regulation of epithelial cell apoptotic process(GO:1904036) |
0.0 | 0.3 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.7 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 1.3 | GO:0048925 | sensory system development(GO:0048880) lateral line system development(GO:0048925) |
0.0 | 2.5 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.2 | GO:0008406 | gonad development(GO:0008406) |
0.0 | 2.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 1.1 | GO:0048545 | response to steroid hormone(GO:0048545) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.3 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.0 | 0.4 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.4 | GO:0098542 | defense response to other organism(GO:0098542) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.2 | GO:0051262 | protein tetramerization(GO:0051262) |
0.0 | 0.1 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.0 | 0.1 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) |
0.0 | 2.1 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.0 | 1.7 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.0 | 0.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 0.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.0 | 0.1 | GO:1900145 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) |
0.0 | 0.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.0 | 0.4 | GO:0060563 | neuroepithelial cell differentiation(GO:0060563) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.2 | GO:0003094 | glomerular filtration(GO:0003094) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.9 | 2.7 | GO:0043218 | compact myelin(GO:0043218) Schmidt-Lanterman incisure(GO:0043220) |
0.9 | 2.6 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.7 | 8.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 1.0 | GO:0098556 | cytoplasmic side of rough endoplasmic reticulum membrane(GO:0098556) |
0.3 | 1.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 1.5 | GO:0097433 | dense body(GO:0097433) |
0.3 | 5.8 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 1.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 1.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 1.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.7 | GO:0005948 | acetolactate synthase complex(GO:0005948) |
0.2 | 1.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.9 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.2 | 1.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.6 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.2 | 4.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.5 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 4.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 0.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 1.9 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.2 | 2.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 18.8 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 0.7 | GO:0034362 | mature chylomicron(GO:0034359) low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.1 | 13.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 1.1 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 8.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 2.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.4 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.1 | 1.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.8 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 1.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 2.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.5 | GO:0070390 | transcription export complex 2(GO:0070390) |
0.1 | 0.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 1.4 | GO:0070187 |